Fundz

Hangzhou Qihan Biotech Co., Ltd. Appoints Mr. Yingyong Xu as Chief Medical Officer

PRIVATEMay 09, 2024

Position

Chief Medical Officer

Company

Qihan Biotech

Yingyong Xu
yingyongxu@qihanbio.com
HangzhouBiotechnologyHealth CareMedicalTherapeutics

Description

Hangzhou Qihan Biotech Co, Ltd announced the appointment of Mr Yingyong Xu as the Chief Medical Officer. Mr Xu brings over two decades of specialized expertise in clinical treatment and innovative drug development in hematology and oncology.

Quick answer

Hangzhou Qihan Biotech Co., Ltd. Appoints Mr. Yingyong Xu as Chief Medical Officer (May 9, 2024). Qihan Biotech is based in Hangzhou, Zhejiang, China.

Who is the new Chief Medical Officer at Qihan Biotech?
Qihan Biotech named Yingyong Xu Chief Medical Officer, announced May 9, 2024.
What did Qihan Biotech announce on May 9, 2024?
Hangzhou Qihan Biotech Co, Ltd announced the appointment of Mr Yingyong Xu as the Chief Medical Officer. Mr Xu brings over two decades of specialized expertise in clinical treatment and innovative drug development in hematology and oncology.
What does Qihan Biotech do?
Qihan Biotech is a biotechnology company applying genome-editing technology to develop novel cell therapies and organs for transplantation.
Where is Qihan Biotech based?
Qihan Biotech is based in Hangzhou, Zhejiang, China.
Which similar companies made leadership changes around the same time?
Scipher Medicine (May 9, 2024), Wave Life Sciences (May 9, 2024), ALX Oncology (May 7, 2024) and neurocare (May 7, 2024) also announced leadership changes within 45 days of Qihan Biotech.

Source: Fundz verified event record.

Other recent leadership changes in Medical and Therapeutics

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at Qihan Biotech, and when

A new leader at Qihan Biotech brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Qihan Biotech raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Qihan Biotech, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Qihan Biotech. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Qihan Biotech

Location

Hangzhou, Zhejiang, China

About

Qihan Biotech is a biotechnology company applying genome-editing technology to develop novel cell therapies and organs for transplantation. The company’s mission is to use high-throughput, multiplexable genome editing in combination with expertise in transplantation immunology to create immunologically privileged allogeneic cells and xenogeneic organs for use as therapies to treat cancer, organ failure, and other important medical conditions. With a vision to create a world in which cell and organ therapies are universally available to patients, Qihan Biotech has raised three rounds of financing and is advancing its cell therapy programs into IND-enabling investigations.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Qihan Biotech changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Luhan
Likely contact at this company
••••••••@••••••••

See Luhan's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Qihan Biotech's next move

Learn about Strategic plan

Qihan Biotech changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.